| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 11/01/2006 | CN1856468A Pyridylacetylenes for use as radiotracers and imaging agents |
| 11/01/2006 | CN1856308A Excitatory amino acid receptor antagonists |
| 11/01/2006 | CN1856306A Aerosol formulation for inhalation comprising an anticholinergic |
| 11/01/2006 | CN1854151A Dopamine transfer protein peptide inhibitor and its use |
| 11/01/2006 | CN1853730A Modified cytokines for use in cancer therapy |
| 11/01/2006 | CN1853645A Combined preparations comprising morpholine anthracyclines and anticancer agent |
| 11/01/2006 | CN1853642A Combined preparations comprising morpholine anthracyclines and anticancer agent |
| 11/01/2006 | CN1853512A Ingredient of mung Chinese medicinal composite beverage and production thereof |
| 11/01/2006 | CN1853493A Peach flower beauty tea |
| 11/01/2006 | CN1282644C Indane or indoline derivative |
| 11/01/2006 | CN1282643C Intermediate for preparing compounds having serotonin-2 receptor antagonistic and alpha-1 blocking action and its preparing method |
| 11/01/2006 | CN1282641C Novel naphthylsulfonic acids and related compounds as glucose uptake agonists |
| 10/31/2006 | US7129381 Glucopyranosyloxybenzylbenzene derivatives, medicinal compositions containing the same and intermediates in the production thereof |
| 10/31/2006 | US7129378 Method of preparing amine stereoisomers |
| 10/31/2006 | US7129361 Thienylazolylalkoxyethanamines, their preparation and their application as medicaments |
| 10/31/2006 | US7129358 Oxidizing the corresponding sulfide without sulfone production to product purer omerprazole, lansoprazole, pantoprazole, rabeprazole, etc. |
| 10/31/2006 | US7129356 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives |
| 10/31/2006 | US7129352 Reacting with sodium hydroxide then calcium chloride to form calcium salt derivative; 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors |
| 10/31/2006 | US7129272 Apoptosis inhibitor |
| 10/31/2006 | US7129261 Cytotoxic agents |
| 10/31/2006 | US7129256 Antiparkinsonism drugs |
| 10/31/2006 | US7129253 Compounds |
| 10/31/2006 | US7129250 Neuroprotective and anti-proliferative compounds |
| 10/31/2006 | US7129249 Heterocyclic amide derivatives as inhibitors of glycogen phoshorylase |
| 10/31/2006 | US7129247 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| 10/31/2006 | US7129246 N-adamantlmethyl derivatives and intermediates as pharmaceutical compositions and processes for their preparation |
| 10/31/2006 | US7129243 Respiratory system disorders; cardiovascular disorders; antidiabetic agents; antiarthritic agents; antiinflammatory agents; immunosuppressants |
| 10/31/2006 | US7129241 Pyridazine derivatives |
| 10/31/2006 | US7129240 1,3-dihydro-2H-indol-2one derivatives, process for preparing them and pharmaceutical compositions containing them |
| 10/31/2006 | US7129236 For therapy of immune related responses, tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
| 10/31/2006 | US7129227 Herpes, hepatitis and aids virus; administering phosphatides |
| 10/31/2006 | US7129225 Administering an effective amount of a protein tyrosine kinase inhibitor (containing first and second module) to the patient to protect against or to treat hearing loss |
| 10/31/2006 | US7129207 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cancer, psoriasis and nervous system disorders |
| 10/31/2006 | US7129077 Gene expression inhibition; solid phase synthesis; drug screening; for treating cancer, central nervous system disorders, and chronic obstructive pulmonary disorder |
| 10/31/2006 | US7129073 Regulation of neuronal function through metabotropic glutamate receptor signaling pathways |
| 10/31/2006 | US7129071 Recombinant methods and materials for producing epothilone and epothilone derivatives |
| 10/31/2006 | US7128933 Reducing odors; using mixture containing plant extracts |
| 10/31/2006 | US7128914 Product containing an extract of red algae of the genus Porphyra and methods for protecting cells |
| 10/31/2006 | CA2427289C Fat composition and hexacosanoic acid depressant for oral or enteral administration |
| 10/31/2006 | CA2383599C Methods, kits and compositions for using pyrrole derivatives |
| 10/31/2006 | CA2355886C Substituted oximes and hydrazones as neurokinin antagonists |
| 10/31/2006 | CA2333405C Spill resistant pharmaceutical compositions |
| 10/31/2006 | CA2283457C Polyvalent carbohydrate molecules |
| 10/31/2006 | CA2250047C Monoclonal antibodies binding human growth hormone (hgh) |
| 10/31/2006 | CA2246126C New piperazine compounds |
| 10/31/2006 | CA2186508C Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors |
| 10/31/2006 | CA2142811C Novel glucan preparation |
| 10/26/2006 | WO2006112549A1 Fused heterocyclic compound |
| 10/26/2006 | WO2006112479A1 Nitrogen-containing heterocyclic compound |
| 10/26/2006 | WO2006112451A1 Anti-cancer agent comprising protein c inhibitor |
| 10/26/2006 | WO2006112449A1 NOVEL NON-HUMAN ANIMAL MODEL FOR ALZHEIMER'S DISEASE HAVING DETERIORATED A-β EXCRETION FUNCTION |
| 10/26/2006 | WO2006112365A1 Treatment of pulmonary emphysema with a mesenchymal stem cell |
| 10/26/2006 | WO2006112331A1 Novel condensed pyrrole derivative |
| 10/26/2006 | WO2006112330A1 Inhibitory agent for estrone-3-sulfate transporter activity |
| 10/26/2006 | WO2006112283A1 Anti-fatigue agent |
| 10/26/2006 | WO2006111424A1 Methods for identifying modulators of cb1 and cb2 cannabinoid receptors and their use in wound healing |
| 10/26/2006 | WO2006111198A1 Use of pde-5 inhibitors for endothelial repair of tissues impaired by trauma or disease |
| 10/26/2006 | WO2006057578A3 Method for preventing and correcting a chronic desynchronosis of human organism organs and systems and a chrono-biological correction agent |
| 10/26/2006 | WO2003006628A3 Nad synthetase inhibitors and uses thereof |
| 10/26/2006 | WO2002100445A8 Treatment and composition for wound healing |
| 10/26/2006 | US20060242716 Disease model animal carrying foreign ppar alpha gene transferred thereinto and use thereof |
| 10/26/2006 | US20060241302 Morpholine derivatives |
| 10/26/2006 | US20060241177 Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
| 10/26/2006 | US20060241171 Novel physiologically active substances |
| 10/26/2006 | US20060241168 administering a protein kinase B activating agent comprising (R)-5,6-dimethoxy-2-[2,2,4,6,7-pentamethyl-3-(4-methylphenyl)-2,3-dihydro-1-benzofuran-5-yl]isoindoline; treating depression, posttraumatic stress disorder, Parkinson's disease, Alzheimer's diseases |
| 10/26/2006 | US20060241155 TNF-alpha production inhibitors |
| 10/26/2006 | US20060241146 2-cyano-1-[t-4-(4-acetyl-1-piperazinyl)-1-methyl-r-1-cyclohexylamino]acetylpyrrolidine; dipeptidylpeptidase IV (DPPIV) inhibitor; antidiabetic, insulin resistance, hyperglycemia, obesity; antiproliferative agent for T-cell, HIV, AIDS; arthritis, osteoporosis |
| 10/26/2006 | US20060241132 Spiro derivatives and adhesion molecule inhibitors comprising the same as active ingredient |
| 10/26/2006 | US20060241131 Pyrrolo[2,3-d]pyrimidine compounds |
| 10/26/2006 | US20060241129 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof |
| 10/26/2006 | US20060241126 Phospholipase inhibitors perticularly phospholipase A2 enzyme Lipoprotein Associated Phospholipase A2; N-(1-Methylpiperidin-4-yl)-(2-(2-(2,3-difluorophenyl)ethyl)-4-oxo-4H-pyrido[2,3-d]pyrimidin-1-yl)-N-(4-(4-trifluoromethylphenyl)phenyl)methylacetamide; amidation |
| 10/26/2006 | US20060241112 Kinase inhibitors |
| 10/26/2006 | US20060241096 Agent for preventing or treating organ functional disorders and organ dysfunction |
| 10/26/2006 | US20060241090 Administering to a post menopausal woman an effective amount of 2-methylene -19-nor-20(S)-1 alpha ,25-dihydroxyvitamin D3 |
| 10/26/2006 | US20060241087 Phosphonates useful as modulators of t $g(g)9$g(d)2 lymphocyte activity |
| 10/26/2006 | US20060241051 Metastin derivatives and use thereof |
| 10/26/2006 | US20060241036 Soluble human interleukin 18 receptor-alpha, method of assaying the same, assay kit and medicinal composition |
| 10/26/2006 | US20060240417 Agent controlling the apoptosis induction by p73 |
| 10/26/2006 | US20060240086 Adhesive patch |
| 10/26/2006 | US20060240056 Treatment of skin with adenosine or adenosine analog |
| 10/26/2006 | US20060240038 Cells used as carriers for bacteria |
| 10/26/2006 | US20060240036 I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1 and CD-95 induced apoptosis |
| 10/26/2006 | US20060240023 Apoptosis-associated protein and use thereof |
| 10/26/2006 | US20060240020 Inhibition of complement activation |
| 10/26/2006 | US20060240019 Antagonists of HMG1 for treating inflammatory conditions |
| 10/26/2006 | US20060240011 Use of nf-kappa b inhibitors for the treatment of mastitis |
| 10/26/2006 | US20060240010 Methods of modulating CD200 receptors |
| 10/26/2006 | US20060240004 Methods for treating tweak-related conditions |
| 10/26/2006 | US20060240000 Combination treatments for allergic disease comprising administering an anti-IgE antibody and antiallergic compound |
| 10/26/2006 | US20060239999 Preventive and/or therapeutic drugs for asthma |
| 10/26/2006 | US20060239993 Containing a mutant angiotensin-converting enzyme that releases glycosylphosphatidylinositol-anchored protein from cell surfaces; for treating a prion-related disease, a bacterial infectious disease or male infertility due to sperm-egg binding insufficiency |
| 10/26/2006 | US20060239991 polypeptide has the biological activity of methionyl tRNA synthetase; for the protection against bacterial infections |
| 10/26/2006 | US20060239959 Method for treating hypercholesterolemia with polyallylamine polymers |
| 10/26/2006 | US20060239957 Using extract of olive leaves |
| 10/26/2006 | US20060239936 Delivery of anti-migraine compounds through an inhalation route |
| 10/26/2006 | DE4244539B4 Duale Inhibitoren der No-Synthese und Cyclooxygenase, Verfahren zu ihrer Herstellung und therapeutische Präparate, die sie enthalten Dual inhibitors of NO synthesis and cyclooxygenase, processes for their preparation and therapeutic compositions containing them |
| 10/26/2006 | CA2610446A1 Nitrogen-containing heterocyclic compound |
| 10/26/2006 | CA2605778A1 Fused heterocyclic compound |
| 10/25/2006 | EP1715040A2 Zinc finger binding domains for GNN |
| 10/25/2006 | EP1715035A2 Synthetic polynucleotides encoding lysyl oxidase |